author_facet Moir, Robert D.
Martins, Ralph N.
Bush, Ashley I.
Small, David H.
Milward, Elizabeth A.
Rumble, Baden A.
Multhaup, Gerd
Beyreuther, Konrad
Masters, Colin L.
Moir, Robert D.
Martins, Ralph N.
Bush, Ashley I.
Small, David H.
Milward, Elizabeth A.
Rumble, Baden A.
Multhaup, Gerd
Beyreuther, Konrad
Masters, Colin L.
author Moir, Robert D.
Martins, Ralph N.
Bush, Ashley I.
Small, David H.
Milward, Elizabeth A.
Rumble, Baden A.
Multhaup, Gerd
Beyreuther, Konrad
Masters, Colin L.
spellingShingle Moir, Robert D.
Martins, Ralph N.
Bush, Ashley I.
Small, David H.
Milward, Elizabeth A.
Rumble, Baden A.
Multhaup, Gerd
Beyreuther, Konrad
Masters, Colin L.
Journal of Neurochemistry
Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
Cellular and Molecular Neuroscience
Biochemistry
author_sort moir, robert d.
spelling Moir, Robert D. Martins, Ralph N. Bush, Ashley I. Small, David H. Milward, Elizabeth A. Rumble, Baden A. Multhaup, Gerd Beyreuther, Konrad Masters, Colin L. 0022-3042 1471-4159 Wiley Cellular and Molecular Neuroscience Biochemistry http://dx.doi.org/10.1111/j.1471-4159.1992.tb08465.x <jats:p><jats:bold>Abstract: </jats:bold> The major component of the amyloid deposition that characterizes Alzheimer's disease is the 4‐kDa βA4 protein, which is derived from a much larger amyloid protein precursor (APP). A procedure for the complete purification of APP from human brain is described. The same amino terminal sequence of APP was found in two patients with Alzheimer's disease and one control subject. Two major forms of APP were identified in human brain with apparent molecular masses of 100–110 kDa and 120–130 kDa. Soluble and membrane fractions of brain contained nearly equal amounts of APP in both humans and rats. Immunoprecipitation with carboxyl terminus‐directed antibodies indicates that the soluble forms of APP are truncated. Carboxyl terminus truncation of membrane‐associated forms of human brain APP was also found to occur during postmortem autolysis. The availability of purified human brain APP will facilitate the investigation of its normal function and the events that lead to its abnormal cleavage in patients with Alzheimer's disease.</jats:p> Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization Journal of Neurochemistry
doi_str_mv 10.1111/j.1471-4159.1992.tb08465.x
facet_avail Online
finc_class_facet Biologie
Psychologie
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4xOTkyLnRiMDg0NjUueA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4xOTkyLnRiMDg0NjUueA
institution DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint Wiley, 1992
imprint_str_mv Wiley, 1992
issn 0022-3042
1471-4159
issn_str_mv 0022-3042
1471-4159
language English
mega_collection Wiley (CrossRef)
match_str moir1992humanbrainba4amyloidproteinprecursorofalzheimersdiseasepurificationandpartialcharacterization
publishDateSort 1992
publisher Wiley
recordtype ai
record_format ai
series Journal of Neurochemistry
source_id 49
title Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_unstemmed Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_full Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_fullStr Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_full_unstemmed Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_short Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_sort human brain βa4 amyloid protein precursor of alzheimer's disease: purification and partial characterization
topic Cellular and Molecular Neuroscience
Biochemistry
url http://dx.doi.org/10.1111/j.1471-4159.1992.tb08465.x
publishDate 1992
physical 1490-1498
description <jats:p><jats:bold>Abstract: </jats:bold> The major component of the amyloid deposition that characterizes Alzheimer's disease is the 4‐kDa βA4 protein, which is derived from a much larger amyloid protein precursor (APP). A procedure for the complete purification of APP from human brain is described. The same amino terminal sequence of APP was found in two patients with Alzheimer's disease and one control subject. Two major forms of APP were identified in human brain with apparent molecular masses of 100–110 kDa and 120–130 kDa. Soluble and membrane fractions of brain contained nearly equal amounts of APP in both humans and rats. Immunoprecipitation with carboxyl terminus‐directed antibodies indicates that the soluble forms of APP are truncated. Carboxyl terminus truncation of membrane‐associated forms of human brain APP was also found to occur during postmortem autolysis. The availability of purified human brain APP will facilitate the investigation of its normal function and the events that lead to its abnormal cleavage in patients with Alzheimer's disease.</jats:p>
container_issue 4
container_start_page 1490
container_title Journal of Neurochemistry
container_volume 59
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339329623785473
geogr_code not assigned
last_indexed 2024-03-01T15:46:21.212Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Human+Brain+%CE%B2A4+Amyloid+Protein+Precursor+of+Alzheimer%27s+Disease%3A+Purification+and+Partial+Characterization&rft.date=1992-10-01&genre=article&issn=1471-4159&volume=59&issue=4&spage=1490&epage=1498&pages=1490-1498&jtitle=Journal+of+Neurochemistry&atitle=Human+Brain+%CE%B2A4+Amyloid+Protein+Precursor+of+Alzheimer%27s+Disease%3A+Purification+and+Partial+Characterization&aulast=Masters&aufirst=Colin+L.&rft_id=info%3Adoi%2F10.1111%2Fj.1471-4159.1992.tb08465.x&rft.language%5B0%5D=eng
SOLR
_version_ 1792339329623785473
author Moir, Robert D., Martins, Ralph N., Bush, Ashley I., Small, David H., Milward, Elizabeth A., Rumble, Baden A., Multhaup, Gerd, Beyreuther, Konrad, Masters, Colin L.
author_facet Moir, Robert D., Martins, Ralph N., Bush, Ashley I., Small, David H., Milward, Elizabeth A., Rumble, Baden A., Multhaup, Gerd, Beyreuther, Konrad, Masters, Colin L., Moir, Robert D., Martins, Ralph N., Bush, Ashley I., Small, David H., Milward, Elizabeth A., Rumble, Baden A., Multhaup, Gerd, Beyreuther, Konrad, Masters, Colin L.
author_sort moir, robert d.
container_issue 4
container_start_page 1490
container_title Journal of Neurochemistry
container_volume 59
description <jats:p><jats:bold>Abstract: </jats:bold> The major component of the amyloid deposition that characterizes Alzheimer's disease is the 4‐kDa βA4 protein, which is derived from a much larger amyloid protein precursor (APP). A procedure for the complete purification of APP from human brain is described. The same amino terminal sequence of APP was found in two patients with Alzheimer's disease and one control subject. Two major forms of APP were identified in human brain with apparent molecular masses of 100–110 kDa and 120–130 kDa. Soluble and membrane fractions of brain contained nearly equal amounts of APP in both humans and rats. Immunoprecipitation with carboxyl terminus‐directed antibodies indicates that the soluble forms of APP are truncated. Carboxyl terminus truncation of membrane‐associated forms of human brain APP was also found to occur during postmortem autolysis. The availability of purified human brain APP will facilitate the investigation of its normal function and the events that lead to its abnormal cleavage in patients with Alzheimer's disease.</jats:p>
doi_str_mv 10.1111/j.1471-4159.1992.tb08465.x
facet_avail Online
finc_class_facet Biologie, Psychologie, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4xOTkyLnRiMDg0NjUueA
imprint Wiley, 1992
imprint_str_mv Wiley, 1992
institution DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 0022-3042, 1471-4159
issn_str_mv 0022-3042, 1471-4159
language English
last_indexed 2024-03-01T15:46:21.212Z
match_str moir1992humanbrainba4amyloidproteinprecursorofalzheimersdiseasepurificationandpartialcharacterization
mega_collection Wiley (CrossRef)
physical 1490-1498
publishDate 1992
publishDateSort 1992
publisher Wiley
record_format ai
recordtype ai
series Journal of Neurochemistry
source_id 49
spelling Moir, Robert D. Martins, Ralph N. Bush, Ashley I. Small, David H. Milward, Elizabeth A. Rumble, Baden A. Multhaup, Gerd Beyreuther, Konrad Masters, Colin L. 0022-3042 1471-4159 Wiley Cellular and Molecular Neuroscience Biochemistry http://dx.doi.org/10.1111/j.1471-4159.1992.tb08465.x <jats:p><jats:bold>Abstract: </jats:bold> The major component of the amyloid deposition that characterizes Alzheimer's disease is the 4‐kDa βA4 protein, which is derived from a much larger amyloid protein precursor (APP). A procedure for the complete purification of APP from human brain is described. The same amino terminal sequence of APP was found in two patients with Alzheimer's disease and one control subject. Two major forms of APP were identified in human brain with apparent molecular masses of 100–110 kDa and 120–130 kDa. Soluble and membrane fractions of brain contained nearly equal amounts of APP in both humans and rats. Immunoprecipitation with carboxyl terminus‐directed antibodies indicates that the soluble forms of APP are truncated. Carboxyl terminus truncation of membrane‐associated forms of human brain APP was also found to occur during postmortem autolysis. The availability of purified human brain APP will facilitate the investigation of its normal function and the events that lead to its abnormal cleavage in patients with Alzheimer's disease.</jats:p> Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization Journal of Neurochemistry
spellingShingle Moir, Robert D., Martins, Ralph N., Bush, Ashley I., Small, David H., Milward, Elizabeth A., Rumble, Baden A., Multhaup, Gerd, Beyreuther, Konrad, Masters, Colin L., Journal of Neurochemistry, Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization, Cellular and Molecular Neuroscience, Biochemistry
title Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_full Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_fullStr Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_full_unstemmed Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_short Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
title_sort human brain βa4 amyloid protein precursor of alzheimer's disease: purification and partial characterization
title_unstemmed Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization
topic Cellular and Molecular Neuroscience, Biochemistry
url http://dx.doi.org/10.1111/j.1471-4159.1992.tb08465.x